(d)
the Member State in which the marketing authorisation is valid and the marketing status of the medicinal product in each Member State;
← art_9__para_3__point_c__text_1 · All articles · art_9__para_3__point_d__text_1 →
Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.